Related Experiment Video
Updated: May 27, 2026
04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
A new medical therapy for Cushing disease?
1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. fwondisford@jhmi.edu
The Journal of Clinical Investigation
|November 23, 2011
Summary
A novel tyrosine kinase inhibitor (TKI) targeting the epidermal growth factor receptor (EGFR) shows promise for treating Cushing disease. This EGFR inhibitor may reduce pituitary tumor size before surgery or manage recurrent disease.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- ErbB family receptor tyrosine kinases are crucial in cancer.
- Pituitary corticotroph adenomas cause Cushing disease.
- Current treatments include surgery, with limitations for recurrent or large tumors.
Purpose of the Study:
- To investigate the potential of targeting epidermal growth factor receptor (EGFR) with tyrosine kinase inhibitors (TKIs) for Cushing disease treatment.
- To explore EGFR-TKI as a neoadjuvant or adjuvant therapy for pituitary corticotroph adenomas.
Main Methods:
- The study by Fukuoka et al. generated data on EGFR-TKI efficacy.
- The specific methods used to generate these data are detailed in the full publication.
Main Results:
- Data suggest that targeting EGFR with a TKI may be a viable therapeutic strategy.
- This approach could potentially reduce tumor burden in patients with Cushing disease.
Conclusions:
- EGFR-TKIs represent a novel therapeutic avenue for hypercortisolemia caused by pituitary corticotroph adenomas.
- TKIs might be used to shrink tumors preoperatively or treat residual/recurrent disease post-surgery.
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: